Drug related | Host related |
High dose | Female gender |
Parenteral administration | Age (less frequent in infants and elderly) |
Large molecular weight agent | Diseases requiring repeated courses of therapy (such as cystic fibrosis) |
Concomitant use of other medications | Genetics (specific HLA types) |
Repetitive courses of the same medication. |